Several medications have been reported to alter the subjective effects of e
xperimentally administered cocaine. We studied the effects of selegiline, a
monoamine oxidase B inhibitor, on the subjective effects of experimentally
administered cocaine in chronically cocaine-dependent subjects. Eight subj
ects completed a protocol that involved repeated administrations of cocaine
before and after treatment with selegiline, given in extended release form
, 10 mg per day, Four days of treatment with selegiline was associated with
decreased self-reported 'high' and 'stimulated' feelings after cocaine adm
inistration, measured as the area under the curve. Changes in other subject
ive effects were less pronounced. Selegiline pretreatment had minimal effec
ts on the cardiovascular responses to cocaine administration. (C) 1999 Else
vier Science Ireland Ltd. All rights reserved.